Oculis Holding AG (OCS) Short-term Investments (2023 - 2026)

Oculis Holding AG (OCS) recorded quarterly Short-term Investments of $201.1 million in Q1 2026, up 22.05% quarter-over-quarter from $164.8 million in Q4 2025, and up 48.13% on a YoY basis from $135.8 million in Q1 2025.

Oculis Holding AG (OCS) Short-term Investments (2023 - 2026) Analysis & Trends

Oculis Holding AG's Short-term Investments history runs 4 years deep, the most recent figure standing at $201.1 million for Q1 2026.

  • In Q1 2026, Short-term Investments rose 48.13% year-over-year to $201.1 million; the TTM figure through Mar 2026 stood at $201.1 million (up 48.13% YoY), while the FY2025 annual figure was $164.8 million, up 103.41% from the prior year.
  • Short-term Investments was $201.1 million for Q1 2026 at Oculis Holding AG, up from $164.8 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $201.1 million in Q1 2026 to a low of $60.1 million in Q4 2023.
  • Historically, Short-term Investments has averaged $106.2 million across 4 years, with a median of $83.9 million in 2024.
  • The sharpest annual moves came in 2024 and 2025: Short-term Investments declined 6.15% in 2024, then soared 113.22% in 2025.
  • A 4-year view of Short-term Investments shows it stood at $60.1 million in 2023, then soared by 34.74% to $81.0 million in 2024, then jumped by 103.41% to $164.8 million in 2025, then rose by 22.05% to $201.1 million in 2026.
  • The last three Short-term Investments figures came in at $201.1 million (Q1 2026), $164.8 million (Q4 2025), and $123.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn -
7 Psyence Biomedical 229.39 Bn 229.38 Bn -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn
9 Abivax 90.15 Bn 90.15 Bn -
10 Oculis Holding AG 8.23 Bn 7.92 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 201.09 Mn
Dec 31, 2025 164.76 Mn
Sep 30, 2025 123.44 Mn
Jun 30, 2025 116.00 Mn
Mar 31, 2025 135.76 Mn
Dec 31, 2024 81.00 Mn
Sep 30, 2024 80.61 Mn
Jun 30, 2024 81.91 Mn
Mar 31, 2024 63.67 Mn
Dec 31, 2023 60.12 Mn
Sep 30, 2023 85.90 Mn
Jun 30, 2023 80.16 Mn